Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genetic Services Laboratory, |
RCV000116283 | SCV000150201 | benign | not specified | 2013-07-15 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000116283 | SCV000851869 | likely benign | not specified | 2015-12-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV000088651 | SCV005206729 | likely benign | not provided | criteria provided, single submitter | not provided | ||
OMIM | RCV000088651 | SCV000121573 | uncertain significance | not provided | 2013-08-08 | no assertion criteria provided | literature only | |
Diagnostic Laboratory, |
RCV000604777 | SCV000734729 | likely benign | Intellectual disability, X-linked 88 | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000088651 | SCV001799633 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000116283 | SCV001974059 | benign | not specified | no assertion criteria provided | clinical testing |